Harvard Bioscience (HBIO) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Harvard Bioscience Revenue Highlights

Latest Revenue (Y)

$94.14M

Latest Revenue (Q)

$20.59M

Main Segment (Y)

Instruments, Equipment, Software, and Accessories

Main Geography (Y)

UNITED STATES

Harvard Bioscience Revenue by Period

Harvard Bioscience Revenue by Year

Date	Revenue	Change
2024-12-31	$94.14M	-16.14%
2023-12-31	$112.25M	-0.96%
2022-12-31	$113.33M	-4.68%
2021-12-31	$118.90M	16.46%
2020-12-31	$102.10M	-12.12%
2019-12-31	$116.18M	-3.81%
2018-12-31	$120.77M	18.54%
2017-12-31	$101.88M	-2.52%
2016-12-31	$104.52M	-3.81%
2015-12-31	$108.66M	0.00%
2014-12-31	$108.66M	3.32%
2013-12-31	$105.17M	-5.40%
2012-12-31	$111.17M	2.12%
2011-12-31	$108.86M	0.63%
2010-12-31	$108.18M	26.12%
2009-12-31	$85.77M	-2.59%
2008-12-31	$88.05M	5.57%
2007-12-31	$83.41M	9.49%
2006-12-31	$76.18M	12.98%
2005-12-31	$67.43M	-27.18%
2004-12-31	$92.60M	6.26%
2003-12-31	$87.14M	51.87%
2002-12-31	$57.38M	40.40%
2001-12-31	$40.87M	33.67%
2000-12-31	$30.57M	16.80%
1999-12-31	$26.18M	115.38%
1998-12-31	$12.15M	-

Harvard Bioscience generated $94.14M in revenue during NA 2024, up -16.14% compared to the previous quarter, and up 81.03% compared to the same period a year ago.

Harvard Bioscience Revenue by Quarter

Date	Revenue	Change
2025-09-30	$20.59M	0.69%
2025-06-30	$20.45M	-6.08%
2025-03-31	$21.77M	-11.33%
2024-12-31	$24.56M	11.77%
2024-09-30	$21.97M	-4.88%
2024-06-30	$23.10M	-5.77%
2024-03-31	$24.51M	-12.93%
2023-12-31	$28.15M	11.00%
2023-09-30	$25.36M	-11.81%
2023-06-30	$28.76M	-4.06%
2023-03-31	$29.98M	5.45%
2022-12-31	$28.43M	5.59%
2022-09-30	$26.92M	-7.83%
2022-06-30	$29.21M	1.49%
2022-03-31	$28.78M	-12.94%
2021-12-31	$33.05M	11.44%
2021-09-30	$29.66M	1.60%
2021-06-30	$29.20M	8.18%
2021-03-31	$26.99M	-12.89%
2020-12-31	$30.98M	28.90%
2020-09-30	$24.04M	3.13%
2020-06-30	$23.31M	-1.95%
2020-03-31	$23.77M	-23.25%
2019-12-31	$30.97M	12.96%
2019-09-30	$27.42M	-7.32%
2019-06-30	$29.58M	4.90%
2019-03-31	$28.20M	-16.71%
2018-12-31	$33.86M	18.24%
2018-09-30	$28.64M	-9.16%
2018-06-30	$31.52M	17.80%
2018-03-31	$26.76M	-2.56%
2017-12-31	$27.46M	9.63%
2017-09-30	$25.05M	-0.65%
2017-06-30	$25.21M	4.38%
2017-03-31	$24.16M	-8.55%
2016-12-31	$26.41M	5.63%
2016-09-30	$25.01M	-4.32%
2016-06-30	$26.14M	-3.07%
2016-03-31	$26.96M	-4.96%
2015-12-31	$28.37M	10.26%
2015-09-30	$25.73M	-10.66%
2015-06-30	$28.80M	11.79%
2015-03-31	$25.76M	-15.15%
2014-12-31	$30.36M	19.32%
2014-09-30	$25.45M	-5.60%
2014-06-30	$26.96M	4.11%
2014-03-31	$25.89M	-7.04%
2013-12-31	$27.85M	10.81%
2013-09-30	$25.14M	-3.67%
2013-06-30	$26.09M	0.03%
2013-03-31	$26.09M	-7.66%
2012-12-31	$28.25M	8.22%
2012-09-30	$26.10M	-8.39%
2012-06-30	$28.50M	0.61%
2012-03-31	$28.32M	-2.43%
2011-12-31	$29.03M	10.03%
2011-09-30	$26.38M	-2.81%
2011-06-30	$27.14M	3.16%
2011-03-31	$26.31M	-10.87%
2010-12-31	$29.52M	11.60%
2010-09-30	$26.45M	2.12%
2010-06-30	$25.91M	-1.50%
2010-03-31	$26.30M	-4.89%
2009-12-31	$27.65M	31.69%
2009-09-30	$21.00M	16.34%
2009-06-30	$18.05M	-5.36%
2009-03-31	$19.07M	-17.27%
2008-12-31	$23.05M	15.32%
2008-09-30	$19.99M	-13.28%
2008-06-30	$23.05M	4.96%
2008-03-31	$21.96M	-10.48%
2007-12-31	$24.53M	-

Harvard Bioscience generated $20.59M in revenue during Q3 2025, up 0.69% compared to the previous quarter, and up 89.15% compared to the same period a year ago.

Harvard Bioscience Revenue Breakdown

Harvard Bioscience Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Service, Maintenance, and Warranty Contracts	$7.17M	$6.53M	$5.17M	$4.79M	-
Instruments, Equipment, Software, and Accessories	$86.96M	$105.72M	$108.17M	$114.11M	-
Service	-	-	-	-	$11.00K
Customer Advances	-	-	-	-	-

Harvard Bioscience's latest annual revenue breakdown by segment (product or service), as of Dec 24: Instruments, Equipment, Software, and Accessories (92.38%), and Service, Maintenance, and Warranty Contracts (7.62%).

Quarterly Revenue by Product

Product/Service	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20
Instruments, Equipment, Software, and Accessories	$18.58M	$18.18M	$19.86M	$43.66M	$20.54M	$22.76M	$26.45M	$23.50M	$27.27M	$28.49M	$27.16M	$25.70M	$27.77M	$27.54M	$31.81M	$28.48M	$27.99M	$25.83M	-	-
Service, Maintenance, and Warranty Contracts	$2.01M	$2.27M	$1.91M	$3.99M	$1.43M	$1.75M	$1.70M	$1.86M	$1.49M	$1.48M	$1.27M	$1.22M	$1.44M	$1.24M	$1.24M	$1.18M	$1.21M	$1.16M	-	-
Service	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$16.00K	$1.04M
Customer Advances	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$387.00K

Harvard Bioscience's latest quarterly revenue breakdown by segment (product or service), as of Sep 25: Instruments, Equipment, Software, and Accessories (90.24%), and Service, Maintenance, and Warranty Contracts (9.76%).

Harvard Bioscience Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
EMEA	$28.41M	-	-	-	-
Greater China	$13.30M	$18.49M	$16.39M	-	-
UNITED STATES	$41.74M	$48.20M	$49.91M	$49.83M	$4.63M
Americas, Other	$3.60M	-	-	-	-
Asia, Other	$7.10M	-	-	-	-
Rest of the World	-	$12.76M	$16.34M	$8.49M	-
Europe	-	$32.80M	$30.69M	$35.77M	-
CHINA	-	-	-	$24.82M	-

Harvard Bioscience's latest annual revenue breakdown by geography, as of Dec 24: UNITED STATES (44.34%), EMEA (30.17%), Greater China (14.13%), Asia, Other (7.54%), and Americas, Other (3.82%).

Quarterly Revenue by Country

Country	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20
EMEA	$6.61M	$6.59M	$6.03M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Asia, Other	$1.40M	$1.33M	$2.35M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
UNITED STATES	$9.25M	$9.66M	$9.83M	$21.05M	$9.71M	$10.98M	$11.55M	$12.02M	$12.34M	$12.30M	$11.63M	$11.51M	$14.07M	$12.24M	$12.53M	$12.71M	$13.15M	$11.18M	$1.17M	$1.91M
Americas, Other	$1.19M	$422.00K	$829.00K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
CHINA	$2.15M	$2.45M	$2.73M	$6.73M	$5.62M	$6.73M	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Greater China	-	-	-	$6.18M	$2.73M	$4.38M	$10.86M	$3.49M	$4.14M	-	-	-	-	-	-	-	-	-	-	-
Rest of the World	-	-	-	-	$3.03M	$2.57M	$5.56M	$2.79M	$2.96M	$1.45M	$11.15M	$1.34M	$2.32M	$1.98M	$4.10M	$1.43M	$2.33M	$1.69M	$7.00K	-
Europe	-	-	-	-	$6.50M	$6.58M	$8.96M	$7.06M	$9.33M	$7.44M	$8.33M	$7.34M	$7.19M	$7.82M	$10.20M	$8.37M	$8.03M	$8.59M	-	-
HONG KONG	-	-	-	-	-	-	-	-	-	$3.51M	-	-	-	-	-	-	-	-	-	-
Rest of Asia	-	-	-	-	-	-	-	-	-	$5.27M	-	-	-	-	-	-	-	-	-	-
Asia	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$7.16M	$5.70M	$5.54M	-	-
GERMANY	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$36.00K

Harvard Bioscience's latest quarterly revenue breakdown by geography, as of Sep 25: UNITED STATES (44.94%), EMEA (32.10%), CHINA (10.42%), Asia, Other (6.78%), and Americas, Other (5.75%).

Harvard Bioscience Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
HBIO	Harvard Bioscience	$94.14M	$20.59M
COSM	Cosmos Health	$54.43M	$17.11M
CLGN	CollPlant Bio	$10.96M	$98.00K
NXGL	NEXGEL	$8.69M	$2.93M
FEMY	Femasys	$1.63M	$729.39K
NXL	Nexalin	$168.72K	$18.15K
SONN	Sonnet BioTherapeutics	$147.81K	-
NCNA	NuCana	-	-
TAOX	TAO Synergies	-	-

HBIO Revenue FAQ

What is Harvard Bioscience’s yearly revenue?

Harvard Bioscience's yearly revenue for 2024 was $94.14M, representing a decrease of -16.14% compared to 2023. The company's yearly revenue for 2023 was $112.25M, representing a decrease of -0.96% compared to 2022. HBIO's yearly revenue for 2022 was $113.34M, representing a decrease of -4.68% compared to 2021.

What is Harvard Bioscience’s quarterly revenue?

Harvard Bioscience's quarterly revenue for Q3 2025 was $20.59M, a 0.69% increase from the previous quarter (Q2 2025), and a -6.28% decrease year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $20.45M, a -6.08% decrease from the previous quarter (Q1 2025), and a -11.46% decrease year-over-year (Q2 2024). HBIO's quarterly revenue for Q1 2025 was $21.77M, a -11.33% decrease from the previous quarter (Q4 2024), and a -11.17% decrease year-over-year (Q1 2024).

What is Harvard Bioscience’s revenue growth rate?

Harvard Bioscience's revenue growth rate for the last 3 years (2022-2024) was -16.94%, and for the last 5 years (2020-2024) was -7.80%.

What are Harvard Bioscience’s revenue streams?

Harvard Bioscience's revenue streams in c 24 are Service, Maintenance, and Warranty Contracts, and Instruments, Equipment, Software, and Accessories. Service, Maintenance, and Warranty Contracts generated $7.17M in revenue, accounting 7.62% of the company's total revenue, up 9.75% year-over-year. Instruments, Equipment, Software, and Accessories generated $86.96M in revenue, accounting 92.38% of the company's total revenue, down -17.74% year-over-year.

What is Harvard Bioscience’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Harvard Bioscience was Instruments, Equipment, Software, and Accessories. This segment made a revenue of $86.96M, representing 92.38% of the company's total revenue.